ST002468 First approach on the use of samples from fecal occult blood screening kits for metabolomic analysis. Application in colorectal cancer population.
Limit by pathway class:
   Minimum # of metabolites per pathway:

Pathway name (# of metabolites detected in this study)HMDB pathwayKEGG pathway
Glycerolipid Metabolism (1) SMP0000039 map00561
Phospholipid Biosynthesis (1) SMP0000025 map00564
Sphingolipid Metabolism (1) SMP0000034 map00600
Steroid Biosynthesis (2) SMP0000023 map00100
  logo